Showing 25 companies
Oncoustics creates advanced AI solutions for low cost, non-invasive diagnostics and treatment monitoring of diseases with high unmet clinical need, beginning with liver disease. Oncoustics applies AI to raw ultrasound signals to rapidly differentiate healthy versus diseased tissues.
To address the exploding demand for efficacious mental healthcare globally, Mobio Interactive has developed and commercialised an AI-powered digital theragnostic platform that delivers clinically validated psychotherapy programmes personalised to every patient using digital biomarkers that quantify human brain states without relying on a wearable.
PlanetWatchers was founded by ex-military intelligence officers to leverage Synthetic Aperture Radar data and extract real earth insights via AI and ML. With extensive experience in providing support for the agricultural, financial and insurance sectors, PlanetWatchers provides fast and accurate analysis of crop classification, lifecycle, productive and damaged areas. SAR imagery can be captured day and night, without the usual visibility limitations of optical data and is well suited to monitoring extensive areas. The reliability of SAR and the military grade analysis of PlanetWatchers provides real world insight, with broad industry capabilities.
Exo (pronounced “Echo”) is a health information and devices company whose mission is to modernize medical imaging through its high-performance handheld ultrasound platform and artificial intelligence, enabling healthcare professionals to make critical, real-time decisions that ultimately improve patient outcomes. The Exo ultrasound platform combines advances in nano-materials, novel sensor technologies, advanced signal processing and computation with the economies of scale of semiconductor manufacturing to dramatically reduce the cost of imaging.
Path Robotics specializes in robotics, automation, and software and database solutions. It develops methods to solve general problems and apply what they develop to manufacturing. They think about how to make machines learn, adapt, and solve problems. It was founded in 2014 and headquartered in Columbus, Ohio.
Rhaeos is a VC backed, clinical stage digital medical device company developing FlowSense, a platform technology and a noninvasive wireless, wearable skin patch that can assess and monitor flow peripherally throughout the body. The company is initially targeting hydrocephalus, a life threatening condition caused by an abnormal accumulation of cerebrospinal fluid. Implantable shunts, the gold standard treatment, often fail, leading to multiple trips to the emergency room and repeat surgeries. FlowSense is a thermal flow sensor that is mounted on a patient’s skin overlying the shunt to detect shunt flow in minutes, bedside, without capital equipment. Rhaeos has raised $8M in financing, received FDA breakthrough designation, published clinical data in Science and Nature family journals, and is on track for initial market entry in early 2022. Following the launch of the hydrocephalus devices, the company will launch wearables for other chronic medical conditions.
Sepion is an advanced materials company offering a platform suite of highly-tunable nanoscale membranes for multiple industrial markets including batteries, electrowinning, and water treatment. We strive to deliver science-based solutions that create massive economic value while enabling measurable climate change mitigation.
Southie Autonomy provides contract packagers, manufacturers, and retailers with fast and flexible robot arm automation. Our no-code, no-programming software platform makes it easy for any worker to deploy and changeover robot arms in less than 10 minutes. Our software allows for easy automation of secondary packaging assembly, kitting, and palletization. The innovative AI/AR platform creates a program for the robot to follow, enabling it to pick up objects of varying shapes and sizes. No coding, engineering, or highly trained experts are necessary, enabling any operator to redirect a robot arm with simple gestures.
VEERUM is a SaaS provider that applies digital technology to asset ownership, helping our clients build and maintain a better world. VEERUM's Asset Visualization Platform provides stakeholders with the latest tools and information to optimize asset outcomes. VEERUM provides a secure cloud-based web solution enabling data transparency across the entire asset lifecycle. It allows asset stakeholders to view aggregated asset data in the context of a 3D model. All information is available for total audit history of the asset.
At Visolis, we use synthetic biology to manufacture high performance materials. Our systems approach integrates innovations in synthetic biology, chemical catalysis and process scale-up to enable new bio-based manufacturing platforms. Our unique bio-based process enables us to achieve true carbon-negative chemical synthesis. Visolis is located in Hayward, CA and Geleen, Netherlands, with close collaborations with Lawrence Berkeley National Lab, Pacific Northwest National Lab and University of California, Berkeley. We have received funding from the Bill and Melinda Gates Foundation, US Department of Energy, the National Science Foundation and the U.S. Department of Agriculture.
imvaria empowers clinicians to improve patient outcomes through the development and application of modern computer science techniques to complex and serious diseases. The company's Digital Biomarker Platform enables non-invasive diagnostic and therapeutic patient stratification via data science and machine learning. imvaria's lead work is assigned FDA's Breakthrough Device Designation.
Bleximo is revolutionizing the way massively complex problems are solved. We are building first-generation quantum computing systems which address hard-to-solve problems in materials science, pharmacology, finance, machine learning, defense, and more. These systems utilize cryogenically cooled superconducting qubits and microwave integrated circuit technology, and require a close multidisciplinary collaboration among scientists, engineers, and corporate clients.